☰

Sean W. Fanning, Ph.D.

Affiliations: 
2012 Chemistry and Biochemistry Northern Illinois University, DeKalb, IL, United States 
Area:
Biochemistry, Biomedical Engineering
Google:
"Sean Fanning"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
James R. Horn grad student 2012 Northern Illinois University
 (Exploiting the plasticity of the single domain VHH antibody scaffold: Unique hapten recognition and engineered metalloregulation.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Speltz TE, Qiao Z, Swenson CS, et al. (2022) Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domains. Nature Biotechnology
Fanning SW, Greene G, Conlan MG. (2020) X-ray crystal structure analysis of elacestrant (RAD1901), a novel selective estrogen receptor degrader (SERD), bound to estrogen receptor alpha ligand binding domain. Journal of Clinical Oncology. 38: e15647-e15647
Ren P, Fanning SW, Tiede C, et al. (2020) Efficient Labeling of Estrogen Receptor α Inside Cells using Affimer, an Antibody Mimetic Biophysical Journal. 118: 470a
Montgomery JE, Donnelly JA, Fanning SW, et al. (2019) Versatile peptide macrocyclization with Diels-Alder cycloadditions. Journal of the American Chemical Society
Fanning S, Laine M, Greene M, et al. (2019) SUN-006 Lasofoxifene Achieves Potent Anti-Tumor Activity in Hormone-Resistant Breast Tumors by Maintaining High Affinity Binding for Y537S ERα Journal of the Endocrine Society. 3
Fanning SW, Jeselsohn R, Dharmarajan V, et al. (2018) The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells. Elife. 7
Fanning SW, Hodges-Gallagher L, Myles DC, et al. (2018) Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activity. Nature Communications. 9: 2368
Speltz TE, Mayne CG, Fanning SW, et al. (2018) A "cross-stitched" peptide with improved helicity and proteolytic stability. Organic & Biomolecular Chemistry
Speltz TE, Danes JM, Fanning SW, et al. (2018) Abstract 1810: Stapled peptide inhibitors of mutant estrogen receptor/coactivator interactions Cancer Research. 78: 1810-1810
Fanning SW, Mayne CG, Dharmarajan V, et al. (2016) Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation. Elife. 5
See more...